# FDA Inspection 963103 - Labcorp Early Development Laboratories, Inc. - January 20, 2016

Source: https://www.keypedia.com/records/fda_inspections/labcorp-early-development-laboratories-inc/68e02022-1a83-48b2-a0ea-ff09cf8ac335
Source feed: FDA_Inspections

> FDA Inspection 963103 for Labcorp Early Development Laboratories, Inc. on January 20, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 963103
- Company Name: Labcorp Early Development Laboratories, Inc.
- Inspection Date: 2016-01-20
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1276600 - 2025-07-25](https://www.keypedia.com/records/fda_inspections/labcorp-early-development-laboratories-inc/bd268f96-1ca7-420a-a020-53f7b5b8e1a8)
- [FDA Inspection 1266550 - 2025-04-11](https://www.keypedia.com/records/fda_inspections/labcorp-early-development-laboratories-inc/04f230e7-bd3b-48b9-b63b-a24fd3e94dea)
- [FDA Inspection 1113166 - 2019-11-21](https://www.keypedia.com/records/fda_inspections/labcorp-early-development-laboratories-inc/1826492a-bd9e-4f15-af63-b9e1625e61c7)

Company: https://www.keypedia.com/companies/labcorp-early-development-laboratories-inc/e6487660-cd04-47c4-879b-cc0248eba943

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c